Last Updated: June 22, 2026

DRIZALMA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Drizalma patents expire, and what generic alternatives are available?

Drizalma is a drug marketed by Sun Pharm and is included in one NDA. There are five patents protecting this drug.

The generic ingredient in DRIZALMA is duloxetine hydrochloride. There are forty-two drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the duloxetine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Drizalma

A generic version of DRIZALMA was approved as duloxetine hydrochloride by AUROBINDO PHARMA LTD on December 11th, 2013.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for DRIZALMA?
  • What are the global sales for DRIZALMA?
  • What is Average Wholesale Price for DRIZALMA?
Summary for DRIZALMA
US Patents:0
Applicants:1
NDAs:1
Drug Prices: Drug price information for DRIZALMA
DailyMed Link:DRIZALMA at DailyMed

US Patents and Regulatory Information for DRIZALMA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm DRIZALMA SPRINKLE duloxetine hydrochloride CAPSULE, DELAYED REL PELLETS;ORAL 212516-001 Jul 19, 2019 RX Yes No ⤷  Start Trial ⤷  Start Trial Y ⤷  Start Trial
Sun Pharm DRIZALMA SPRINKLE duloxetine hydrochloride CAPSULE, DELAYED REL PELLETS;ORAL 212516-004 Jul 19, 2019 RX Yes Yes ⤷  Start Trial ⤷  Start Trial Y ⤷  Start Trial
Sun Pharm DRIZALMA SPRINKLE duloxetine hydrochloride CAPSULE, DELAYED REL PELLETS;ORAL 212516-002 Jul 19, 2019 RX Yes No ⤷  Start Trial ⤷  Start Trial Y ⤷  Start Trial
Sun Pharm DRIZALMA SPRINKLE duloxetine hydrochloride CAPSULE, DELAYED REL PELLETS;ORAL 212516-001 Jul 19, 2019 RX Yes No ⤷  Start Trial ⤷  Start Trial Y ⤷  Start Trial
Sun Pharm DRIZALMA SPRINKLE duloxetine hydrochloride CAPSULE, DELAYED REL PELLETS;ORAL 212516-003 Jul 19, 2019 RX Yes No ⤷  Start Trial ⤷  Start Trial Y ⤷  Start Trial
Sun Pharm DRIZALMA SPRINKLE duloxetine hydrochloride CAPSULE, DELAYED REL PELLETS;ORAL 212516-004 Jul 19, 2019 RX Yes Yes ⤷  Start Trial ⤷  Start Trial Y ⤷  Start Trial
Sun Pharm DRIZALMA SPRINKLE duloxetine hydrochloride CAPSULE, DELAYED REL PELLETS;ORAL 212516-002 Jul 19, 2019 RX Yes No ⤷  Start Trial ⤷  Start Trial Y ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
DrugChatter Q&A for DRIZALMA

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.